BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 4931743)

  • 1. Chronic mucocutaneous candidiasis: model-building in cellular immunity.
    Kirkpatrick CH; Rich RR; Bennett JE
    Ann Intern Med; 1971 Jun; 74(6):955-78. PubMed ID: 4931743
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic mucocutaneous candidiasis.
    J Cutan Pathol; 1974; 1(5):211-29. PubMed ID: 4470726
    [No Abstract]   [Full Text] [Related]  

  • 3. Chronic mucocutaneous candidiasis: immunologic and antibiotic therapy.
    Kirkpatrick CH; Smith TK
    Ann Intern Med; 1974 Mar; 80(3):310-20. PubMed ID: 4816171
    [No Abstract]   [Full Text] [Related]  

  • 4. Transfer of cellular hypersensitivity in chronic mucocutaneous candidiasis monitored in vivo and in vitro.
    Rocklin RE; Chilgren RA; Hong R; David JR
    Cell Immunol; 1970 Sep; 1(3):290-9. PubMed ID: 5523582
    [No Abstract]   [Full Text] [Related]  

  • 5. Selective hypopituitarism. Impaired cell-mediated immunity and chronic mucocutaneous candidiasis.
    Arvanitakis C; Knouss RF
    JAMA; 1973 Sep; 225(12):1492-5. PubMed ID: 4740720
    [No Abstract]   [Full Text] [Related]  

  • 6. An evolution of therapy for mucocutaneous candidiasis.
    Kornblut AD
    Laryngoscope; 1980 Jul; 90(7 Pt 2 Suppl 22):1-30. PubMed ID: 7382716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transfer factor in the treatment of a case of chronic mucocutaneous candidiasis.
    Schulking ML; Adler WH; Altemeier WA; Ayoub EM
    Cell Immunol; 1972 Apr; 3(4):606-15. PubMed ID: 4554089
    [No Abstract]   [Full Text] [Related]  

  • 8. Transfer factor as an approach to the treatment of immune deficiency disease.
    Schulkind ML; Ayoub EM
    Birth Defects Orig Artic Ser; 1975; 11(1):436-40. PubMed ID: 1096988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic mucocutaneous candidiasis: a model for the investigation of cell mediated immunity.
    Holt PJ; Higgs JM; Munro J; Valdimarsson H
    Br J Clin Pract; 1972 Jul; 26(7):331-6. PubMed ID: 5074179
    [No Abstract]   [Full Text] [Related]  

  • 10. Immune reconstitution in keratoconjunctivitis and superficial candidiasis. The role of immunocompetent lymphocyte transfusion and transfer factor.
    Wong VG; Kirkpatrick CH
    Arch Ophthalmol; 1974 Oct; 92(4):335-9. PubMed ID: 4413776
    [No Abstract]   [Full Text] [Related]  

  • 11. Chronic mucocutaneous candidiasis of the adult. A report of a patient with an associated thymoma.
    Maize JC; Lynch PJ
    Arch Dermatol; 1972 Jan; 105(1):96-8. PubMed ID: 5009626
    [No Abstract]   [Full Text] [Related]  

  • 12. Mucocutaneous candidiasis, anergy and a plasma inhibitor of cellular immunity: reversal after amphotericin B therapy.
    Paterson PY; Semo R; Blumenschein G; Swelstad J
    Clin Exp Immunol; 1971 Nov; 9(5):595-602. PubMed ID: 4947556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of thymosin on lymphocytes from patients with chronic mucocutaneous candidiasis and endocrinopathies.
    Akhter J; Merker RI; Rieger CH; Rothberg RM
    J Allergy Clin Immunol; 1980 Jan; 65(1):34-40. PubMed ID: 6985631
    [No Abstract]   [Full Text] [Related]  

  • 14. Lymphocyte abnormality in chronic mucocutaneous candidiasis.
    Valdimarsson H; Holt L; Riches HR; Hobbs JR
    Lancet; 1970 Jun; 1(7659):1259-61. PubMed ID: 4192497
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunological defence and transfer factor therapy in chronic mucocutaneous candidiasis].
    Bläker F; Grob PJ; Hellwege HH; Schulz KH
    Dtsch Med Wochenschr; 1973 Mar; 98(9):415-20. PubMed ID: 4691560
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunopathology in foot and hand mycoses and their combined therapy using dekaris].
    Ruslanov DV
    Vestn Dermatol Venerol; 1982 Oct; (10):20-4. PubMed ID: 6983791
    [No Abstract]   [Full Text] [Related]  

  • 17. Lymphocyte abnormality in chronic mucocutaneous candidiasis.
    Valdimarsson H; Holt L; Hobbs JR
    Lancet; 1970 Aug; 2(7666):268-9. PubMed ID: 4193722
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma thymic hormone activity in patients with chronic mucocutaneous candidiasis.
    Kirkpatrick CH; Greenberg LE; Chapman SW; Goldstein G; Lewis VM; Twomey JJ
    Clin Exp Immunol; 1978 Dec; 34(3):311-7. PubMed ID: 743805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of chronic mucocutaneous moniliasis by immunologic reconstitution.
    Kirkpatrick CH; Rich RR; Graw RG; Smith TK; Mickenberg I; Rogentine GN
    Clin Exp Immunol; 1971 Dec; 9(6):733-48. PubMed ID: 4945734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes in the immunoreactivity of patients with dyshidrosis caused by Candida species and treated with desensitization].
    Halmy K; Serfözö J; Tóth-Jakab A
    Dermatol Monatsschr; 1983; 169(7):446-51. PubMed ID: 6628782
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.